Results 121 to 130 of about 36,054 (205)

Expression of HPV-16 L2 in plants

, 2008
Includes bibliographical references (leaves 77-84).This study demonstrates high level expression of L2, 25 mg.kg⁻¹of leaf material, is achievable. Interestingly, expression was best when coded for by a mammalian codon-optimized form of the L2 gene as ...
Ramon Pereira, Pereira, Roman
core  

A Pocket Manual for Human Papillomavirus Vaccines. [PDF]

Vaccines (Basel)
Voss NA, Jackson JB, Rysavy MB.
europepmc   +1 more source

Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines. [PDF]

Lancet Microbe
Schiller JT, Kines RC, Day PM, Çuburu N, Kreimer AR, Lowy DR.   +5 more
europepmc   +1 more source

Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study

Therapeutic vaccination can harness the body’s cellular immune system to target and destroy cancerous cells. Several treatment options are available to eliminate pre-cancerous and cancerous lesions caused by human papillomaviruses (HPV), but may ...
Katherine A. Hodgson, Jonathan D. Lindbloom, Molly R. Braun, Anne C. Moore, Emery G. Dora, Sean N. Tucker   +5 more
core   +1 more source

Evaluation of the feasibility of artificial intelligence models as patient information advisors for human papillomavirus vaccines. [PDF]

Rev Assoc Med Bras (1992)
Kaya A, Kücükdag HN, Keyif B.
europepmc   +1 more source

Author Correction: Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology. [PDF]

NPJ Vaccines
Garcea RL, Meinerz NM, Dong M, Funke H, Ghazvini S, Randolph TW.   +5 more
europepmc   +1 more source

Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers. [PDF]

Genes Dis
Islam MR, Rauf A, Aktar MN, Hossain Fakir MN, Trisha SI, Asif AI, Or Rashid MH, Khalil Al-Imran MI, Thufa GK, Emu FP, Hemeg HA, Ogaly HA, Thiruvengadam R, Kim SH, Thiruvengadam M.   +14 more
europepmc   +1 more source

Prophylactic vaccines against human papillomavirus

, 2007
Source at https://www.helsebiblioteket.no/Denne rapporten er første del av et oppdrag fra Nasjonalt folkehelseinstitutt, med fokus på vurdering av effekt og sikkerhet ved bruk av vaksiner mot humant papillomavirus (HPV).
Steen, Rita, Feiring, Berit, Alfsen, Cecilie G., Skjeldestad, Finn Egil, Sæterdal, Ingvil von Mehren, Nilsen, Ellen M   +5 more
core  

Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review. [PDF]

Hum Vaccin Immunother
Felsher M, Fisher-Borne M, Malik T, Santpurkar N, Martin S, Zaidi O, Wang W, Palmer C.   +7 more
europepmc   +1 more source

Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database. [PDF]

PLoS One
Yan K, Yang G, Yan L, Wu L, Wang Y, He P, Yu Q.   +6 more
europepmc   +1 more source